PMCB

$0.00

(

+0.00%

)
Quote details

stock

PharmaCyte Biotech Inc

NASDAQ | PMCB

0.95

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 3, 2025)

$6.39M

Market Cap

0.292

P/E Ratio

3.19

EPS

$2.42

52 Week High

$0.80

52 Week Low

LIFE SCIENCES

Sector

PMCB Chart

Recent Chart
Price Action

PMCB Technicals

Tags:

PMCB Earnings

Yearly Income Statement (As of Apr 30, 2025)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$4.4T
Selling General And Administrative $3.9M
Research And Development $438K
Operating Expenses $4.4M
Investment Income Net -
Net Interest Income $1.4M
Interest Income $1.4M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax $23T
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $31M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda $31M
Net Income $31M

Revenue & Profitability

Earnings Performance

PMCB Financials

yearly Balance Sheet (As of Apr 30, 2025)

Field Value (USD)
Total Assets $55M
Total Current Assets $22M
Cash And Cash Equivalents At Carrying Value $15M
Cash And Short Term Investments $15M
Inventory -
Current Net Receivables $3.7M
Total Non Current Assets $33M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.5M
Intangible Assets Excluding Goodwill $1.5M
Goodwill -
Investments -
Long Term Investments $22M
Short Term Investments $366K
Other Current Assets $3.1M
Other Non Current Assets -
Total Liabilities $3.3M
Total Current Liabilities $2.9M
Current Accounts Payable $399K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $363K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $2.5M
Other Non Current Liabilities -
Total Shareholder Equity $52M
Treasury Stock -
Retained Earnings -$85M
Common Stock $2.2K
Common Stock Shares Outstanding $7.3M

yearly Cash Flow (As of Apr 30, 2025)

Field Value (USD)
Operating Cashflow -$3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $4
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$7M
Cashflow From Financing -$25M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $1.1M
Dividend Payout Common Stock $1.1M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$25M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $31M

yearly Income Statement (As of Apr 30, 2025)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$4.4T
Selling General And Administrative $3.9M
Research And Development $438K
Operating Expenses $4.4M
Investment Income Net -
Net Interest Income $1.4M
Interest Income $1.4M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax $23T
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $31M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda $31M
Net Income $31M

PMCB News

PMCB Profile

PharmaCyte Biotech Inc Profile

Sector: LIFE SCIENCES

Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California.

UGRO
+50.70%
$0.60
CGBS
-39.47%
$0.03
BURU
+2.77%
$0.16
AIHS
+91.66%
$4.59
NVDA
-0.54%
$169.84
BTBD
+68.16%
$3.11
GOOGL
+8.27%
$228.83
SNAP
+0.06%
$7.33
TPIC
-45.91%
$0.12
TSLA
+1.74%
$335.10
AAL
+0.48%
$13.45
NIO
-5.54%
$6.21
AXDX
-61.36%
$0.03
BINI
-10.24%
$0.18
PLTR
-1.70%
$154.41
LYT
-16.77%
$0.09
GOOG
+8.12%
$229.22
RIVN
+6.84%
$14.82
WBD
+2.02%
$11.85
VHAI
0.00%
$0.00
DNN
+2.85%
$2.34
SOUN
-5.21%
$12.72
NXTT
+1.37%
$0.25
PMN
-11.61%
$0.47
TLRY
-5.56%
$1.18
MARA
-1.49%
$15.82
AAPL
+3.17%
$237.01
KHC
-6.97%
$26.02
CJET
-60.88%
$0.23
LYFT
+1.57%
$17.06
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
M
+17.45%
$15.84
SINT
+15.97%
$5.30
ABEV
-3.42%
$2.11
BTG
-3.22%
$4.13
PLUG
+1.68%
$1.50
SRM
+53.27%
$10.30
SOFI
-1.14%
$24.62
RIOT
-3.95%
$13.53
INTC
-1.28%
$23.90
F
-0.89%
$11.61
BAOS
+9.47%
$3.12
CIFR
-1.08%
$8.23
BMNR
+6.10%
$45.08
JOBY
-1.56%
$13.17
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
IXHL
-2.22%
$0.62
ETWO
0.00%
$3.30
SMR
+10.99%
$41.33
BITF
-1.11%
$1.32
WULF
-6.90%
$8.96
ADAP
-4.67%
$0.05
SBET
-2.65%
$16.53
RKLB
-9.51%
$44.62
RAYA
-8.13%
$0.04
IREN
-2.86%
$28.27
QBTS
-3.22%
$15.33
HIMS
+7.77%
$44.76
AFMD
-34.94%
$0.18
MRVL
-4.40%
$61.75
AMD
-0.69%
$161.19
NOK
+3.19%
$4.36
LCFY
+55.28%
$6.31
PFE
-0.90%
$24.75
KO
-1.41%
$68.08
KDP
+0.39%
$29.02
ETHD
-9.59%
$3.34
IPDN
+15.53%
$8.02
HL
-0.67%
$8.86
BAC
-1.02%
$49.90
RGTI
-2.54%
$15.12
BBD
-0.20%
$3.01
ONDS
-3.90%
$5.24
GRYP
-10.38%
$1.38
RIG
-2.23%
$2.99
MODV
-25.22%
$0.43
KEY
-1.08%
$18.75
GRAB
-0.70%
$4.89
HPE
+0.68%
$22.83
AG
-2.34%
$9.38
HOOD
-0.60%
$100.22
RR
-5.88%
$2.72
BTE
-4.02%
$2.26
LCID
-4.05%
$16.94
HBAN
-1.10%
$17.48
JEM
-63.42%
$0.81
IQ
+0.03%
$2.68
T
-0.31%
$28.98
BTBT
-1.72%
$2.56
MULN
-20.26%
$0.20
URG
+12.40%
$1.54
RZLV
+8.44%
$3.98
ITUB
-1.06%
$6.93
AMZN
-0.28%
$224.70
TSLG
+3.36%
$6.16
CARM
-18.20%
$0.35
PBR
-1.57%
$12.21
UGRO
+50.70%
$0.60
CGBS
-39.47%
$0.03
BURU
+2.77%
$0.16
AIHS
+91.66%
$4.59
NVDA
-0.54%
$169.84
BTBD
+68.16%
$3.11
GOOGL
+8.27%
$228.83
SNAP
+0.06%
$7.33
TPIC
-45.91%
$0.12
TSLA
+1.74%
$335.10
AAL
+0.48%
$13.45
NIO
-5.54%
$6.21
AXDX
-61.36%
$0.03
BINI
-10.24%
$0.18
PLTR
-1.70%
$154.41
LYT
-16.77%
$0.09
GOOG
+8.12%
$229.22
RIVN
+6.84%
$14.82
WBD
+2.02%
$11.85
VHAI
0.00%
$0.00
DNN
+2.85%
$2.34
SOUN
-5.21%
$12.72
NXTT
+1.37%
$0.25
PMN
-11.61%
$0.47
TLRY
-5.56%
$1.18
MARA
-1.49%
$15.82
AAPL
+3.17%
$237.01
KHC
-6.97%
$26.02
CJET
-60.88%
$0.23
LYFT
+1.57%
$17.06
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
M
+17.45%
$15.84
SINT
+15.97%
$5.30
ABEV
-3.42%
$2.11
BTG
-3.22%
$4.13
PLUG
+1.68%
$1.50
SRM
+53.27%
$10.30
SOFI
-1.14%
$24.62
RIOT
-3.95%
$13.53
INTC
-1.28%
$23.90
F
-0.89%
$11.61
BAOS
+9.47%
$3.12
CIFR
-1.08%
$8.23
BMNR
+6.10%
$45.08
JOBY
-1.56%
$13.17
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
IXHL
-2.22%
$0.62
ETWO
0.00%
$3.30
SMR
+10.99%
$41.33
BITF
-1.11%
$1.32
WULF
-6.90%
$8.96
ADAP
-4.67%
$0.05
SBET
-2.65%
$16.53
RKLB
-9.51%
$44.62
RAYA
-8.13%
$0.04
IREN
-2.86%
$28.27
QBTS
-3.22%
$15.33
HIMS
+7.77%
$44.76
AFMD
-34.94%
$0.18
MRVL
-4.40%
$61.75
AMD
-0.69%
$161.19
NOK
+3.19%
$4.36
LCFY
+55.28%
$6.31
PFE
-0.90%
$24.75
KO
-1.41%
$68.08
KDP
+0.39%
$29.02
ETHD
-9.59%
$3.34
IPDN
+15.53%
$8.02
HL
-0.67%
$8.86
BAC
-1.02%
$49.90
RGTI
-2.54%
$15.12
BBD
-0.20%
$3.01
ONDS
-3.90%
$5.24
GRYP
-10.38%
$1.38
RIG
-2.23%
$2.99
MODV
-25.22%
$0.43
KEY
-1.08%
$18.75
GRAB
-0.70%
$4.89
HPE
+0.68%
$22.83
AG
-2.34%
$9.38
HOOD
-0.60%
$100.22
RR
-5.88%
$2.72
BTE
-4.02%
$2.26
LCID
-4.05%
$16.94
HBAN
-1.10%
$17.48
JEM
-63.42%
$0.81
IQ
+0.03%
$2.68
T
-0.31%
$28.98
BTBT
-1.72%
$2.56
MULN
-20.26%
$0.20
URG
+12.40%
$1.54
RZLV
+8.44%
$3.98
ITUB
-1.06%
$6.93
AMZN
-0.28%
$224.70
TSLG
+3.36%
$6.16
CARM
-18.20%
$0.35
PBR
-1.57%
$12.21

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.